Zigang Dong Selected Research

Skin Neoplasms (Skin Cancer)

1/2021	3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo.
8/2020	The effect of metformin on the risk of recurrent nonmelanoma skin cancers.
1/2020	Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032.
10/2018	Targeting PRPK and TOPK for skin cancer prevention and therapy.
10/2017	Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.
1/2017	ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.
1/2017	LTA4H regulates cell cycle and skin carcinogenesis.
1/2017	TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.
11/2016	Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin.
3/2016	Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zigang Dong Research Topics

Disease

230	Neoplasms (Cancer) 05/2022 - 02/2000
78	Carcinogenesis 01/2022 - 12/2002
39	Skin Neoplasms (Skin Cancer) 01/2021 - 12/2002
27	Colonic Neoplasms (Colon Cancer) 03/2021 - 10/2008
21	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 07/2007
21	Inflammation (Inflammations) 11/2021 - 05/2008
20	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2017
19	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2010
19	Melanoma (Melanoma, Malignant) 01/2021 - 08/2005
17	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2007
17	Neoplastic Cell Transformation 03/2016 - 06/2004
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 06/2013
11	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2006
9	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 05/2016
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2012
9	Nasopharyngeal Carcinoma 12/2016 - 10/2011
7	Infections 01/2022 - 12/2012
6	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2012
5	Body Weight (Weight, Body) 01/2021 - 01/2013
5	Leukemia 09/2016 - 06/2007
4	Obesity 01/2020 - 10/2008
4	Carcinoma (Carcinomatosis) 05/2016 - 01/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015 - 11/2010
3	Hypoxia (Hypoxemia) 01/2022 - 05/2010
3	Hyperplasia 01/2021 - 11/2015
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018 - 01/2017
3	Pain (Aches) 03/2016 - 02/2009

Drug/Important Bio-Agent (IBA)

56	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2003
32	Phosphotransferases (Kinase)IBA 11/2021 - 02/2000
21	CarcinogensIBA 01/2022 - 02/2000
20	Biological ProductsIBA 02/2022 - 01/2003
20	Pharmaceutical PreparationsIBA 05/2021 - 09/2006
19	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2003
16	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 07/2007
16	Epidermal Growth Factor (EGF)IBA 09/2016 - 04/2003
12	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2008
12	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 01/2003
11	Histones (Histone)IBA 10/2017 - 07/2005
10	Small Interfering RNA (siRNA)IBA 05/2020 - 06/2004
10	AgarIBA 09/2016 - 01/2006
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2014
9	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2003
9	PhytochemicalsIBA 05/2017 - 04/2010
8	FlavonoidsIBA 01/2021 - 12/2010
7	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 10/2009
7	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 04/2010
7	TeaIBA 09/2014 - 01/2003
7	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2013 - 07/2008
6	ArsenicIBA 09/2012 - 02/2000
6	ResveratrolIBA 12/2010 - 04/2002
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 12/2002
5	CateninsIBA 01/2022 - 12/2013
5	UbiquitinIBA 12/2021 - 06/2012
5	Therapeutic UsesIBA 04/2021 - 05/2016
5	IsoflavonesIBA 01/2021 - 11/2007
5	AntioxidantsIBA 06/2020 - 07/2008
5	EnzymesIBA 12/2019 - 06/2006
5	Gefitinib (Iressa)FDA Link 02/2018 - 07/2013
5	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2016 - 08/2005
5	Mitogen-Activated Protein KinasesIBA 02/2014 - 06/2006
5	Serine (L-Serine)FDA Link 06/2012 - 07/2002
4	Aurora Kinase AIBA 01/2022 - 03/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2006
4	Annexin A5IBA 03/2021 - 06/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2013
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 09/2013
4	Capsaicin (Zostrix)FDA Link 03/2020 - 09/2010
4	NF-kappa B (NF-kB)IBA 09/2019 - 01/2003
4	MicroRNAs (MicroRNA)IBA 04/2019 - 11/2012
4	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 06/2011
4	daidzeinIBA 05/2017 - 11/2007
4	ProstaglandinsIBA 01/2017 - 10/2009
4	Protein Isoforms (Isoforms)IBA 01/2017 - 03/2002
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2015 - 07/2012
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2011 - 03/2008
3	CalciumIBA 02/2022 - 09/2005
3	Thromboxane A2 (A2, Thromboxane)IBA 01/2022 - 01/2017
3	Propidium (Propidium Iodide)IBA 03/2021 - 08/2019
3	Urethane (Ethyl Carbamate)IBA 01/2021 - 01/2018
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2021 - 04/2009
3	Caspase 3 (Caspase-3)IBA 10/2020 - 04/2009
3	Aurora Kinase BIBA 01/2020 - 01/2013
3	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2019 - 01/2011
3	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 08/2019 - 05/2013
3	leukotriene A4 hydrolaseIBA 06/2019 - 07/2009
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 06/2013
3	N,N'-dinitrosopiperazineIBA 12/2018 - 10/2011
3	Cyclin D1IBA 10/2018 - 03/2014
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2017 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 04/2010
3	Caspase 7IBA 11/2015 - 06/2011
3	CaspasesIBA 02/2015 - 09/2006
3	kaempferolIBA 09/2014 - 05/2009
3	Adenosine Triphosphate (ATP)IBA 08/2014 - 09/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2012 - 11/2011

Therapy/Procedure

48	Therapeutics 01/2022 - 02/2000
21	Chemoprevention 01/2022 - 01/2003
8	Drug Therapy (Chemotherapy) 05/2021 - 06/2006
7	Oral Administration 01/2020 - 11/2006